Clinical Features of Thymus Pathology

  • Ghulam Khaleeq
  • Hakim A. Ali
  • Ali I. Musani


Thymus pathology embraces a broad spectrum of features, varying from major immunologic abnormalities affecting all organ systems to minor abnormalities with limited clinical consequences. Some individuals with thymus pathology may have all the features of the disease while others may have only a few features. In this chapter we will review clinical features of common thymus pathologies. Tables 7.1 and 7.2 list the localized and systemic symptoms due to mediastinal tumors [1].


Acquire Immune Deficiency Syndrome Simian Immunodeficiency Virus Cleft Palate Thymic Carcinoma Deletion Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Crapo JD, Glassroth J, Karlinsky J et al (2004) Baum’s textbook of pulmonary diseases. Lippincott Williams & Wilkins, Philadelphia, PAGoogle Scholar
  2. 2.
    Assarsson E, Chambers BJ, Hogstrand K et al (2007) Severe defect in thymic development in an insertional mutant mouse model. J Immunol 178:5018–5027PubMedGoogle Scholar
  3. 3.
    Boehm T, Bleul CC (2007) The evolutionary history of lymphoid organs. Nat Immunol 8:131–135PubMedCrossRefGoogle Scholar
  4. 4.
    Devriendt K, Fryns JP, Mortier G et al (1998) The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet 35:789–90PubMedCrossRefGoogle Scholar
  5. 5.
    Sullivan KE, Jawad AF, Randall P et al (1998) Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes. Clin Immunol Immunopathol 86:141–146PubMedCrossRefGoogle Scholar
  6. 6.
    Kobrynski LJ, Sullivan KE (2007) Velocardiofacial syndrome, DiGeorge syndrome: The chromosome 22q11.2 deletion syndromes. Lancet 370:1443–1452PubMedCrossRefGoogle Scholar
  7. 7.
    McLean-Tooke G, Spickett P, Gennery AR (2007) Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scand J Immunol 66:1–7PubMedCrossRefGoogle Scholar
  8. 8.
    McDonald-McGinn DM, Kirschner R, Goldmuntz E et al (1999) The Philadelphia story: The 22q11.2 deletion: Report on 250 patients. Genet Couns 10:11–24PubMedGoogle Scholar
  9. 9.
    Ryan AK, Goodship JA, Wilson DI et al (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: A European collaborative study. J Med Genet 34:798–804PubMedCrossRefGoogle Scholar
  10. 10.
    Gerdes M, Solot C, Wang PP et al (1999) Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Gene 85:127–133CrossRefGoogle Scholar
  11. 11.
    Moss EM, Batshaw ML, Solot CB et al (1999) Psychoeducational profile of the 22q11.2 microdeletion: A complex pattern. J Pediatr 134:193–198PubMedCrossRefGoogle Scholar
  12. 12.
    Swillen A, Devriendt K, Legius E et al (1997) Intelligence and psychosocial adjustment in velocardiofacial syndrome: A study of 37 children and adolescents with VCFS. J Med Gene 34: 453–458CrossRefGoogle Scholar
  13. 13.
    Wang PP, Woodin MF, Kreps-Falk R et al (2000) Research on behavioral phenotypes: Velocardiofacial syndrome (deletion 22q11.2). Dev Med Child Neurol 42: 422–427PubMedCrossRefGoogle Scholar
  14. 14.
    Weller E, Weller R, Jawad A et al (1999) Psychiatric diagnoses in children with velocardiofacial syndrome, American Academy of Child and Adolescent Psychiatry, ChicagoGoogle Scholar
  15. 15.
    Vantrappen G, Devriendt K, Swillen A et al (1999) Presenting symptoms and clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience, Genet Coun 10:3–9Google Scholar
  16. 16.
    Yan W, Jacobsen LK, Krasnewich DM et al (1998) Chromosome 22q11.2 interstitial deletions among childhood-onset schizophrenics and “multidimensionally impaired”. Am J Med Genet 81:41–4PubMedCrossRefGoogle Scholar
  17. 17.
    Motzkin B, Marion R, Goldberg R et al (1993) Variable phenotypes in velocardiofacial syndrome with chromosomal deletion. J Pediatr 123:406–410PubMedCrossRefGoogle Scholar
  18. 18.
    Shprintzen RJ, Goldberg R, Golding-Kushner KJ et al (1992) Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet 42:141–142PubMedCrossRefGoogle Scholar
  19. 19.
    Lischner HW, Dacou C, DiGeorge AM (1967) Normal lymphocyte transfer (NLT) test: Negative response in a patient with congenital absence of the thymus. Transplantation 5:555PubMedGoogle Scholar
  20. 20.
    Botto LD, May K, Fernhoff PM, Correa A et al (2003) A population-based study of the 22q11.2 deletion: Phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112:101–107PubMedCrossRefGoogle Scholar
  21. 21.
    McDonald-McGinn DM, LaRossa D et al (1997) The 22q11.2 deletion: Screening, diagnostic workup, and outcome of results; report on 181 patients. Genet Test 1:99–108PubMedCrossRefGoogle Scholar
  22. 22.
    Goldmuntz E (2005) DiGeorge Syndrome: New Insights. Clinics in Perinatology 32:963–978PubMedCrossRefGoogle Scholar
  23. 23.
    Wurdak H, Ittner LM, Sommer L (2007) DiGeorge syndrome and pharyngeal apparatus development. Bioessays 28:1078–1086CrossRefGoogle Scholar
  24. 24.
    Eicher PS, McDonald-McGinn DM, Fox CA et al (2000) Dysphagia in children with a 22q11.2 deletion: Unusual pattern found on modified barium swallow. J Pediatr 137:158–164PubMedCrossRefGoogle Scholar
  25. 25.
    Dyce O, McDonald-McGinn D, Kirschner RE et al (2002) Otolaryngologic manifestations of the 22q11.2 deletion syndrome. Arch Otolaryngol Head Neck Surg 128:1408–1412PubMedGoogle Scholar
  26. 26.
    Brauner R, Le Harivel de Gonneville A, Kindermans C et al (2003) Parathyroid function and growth in 22q11.2 deletion syndrome. J Pediatr 142:504–508PubMedCrossRefGoogle Scholar
  27. 27.
    Taylor SC, Morris G, Wilson D et al (2003) Hypoparathyroidism and 22q11 deletion syndrome. Arch Dis Child 88:520–522PubMedCrossRefGoogle Scholar
  28. 28.
    Scire G, Dallapiccola B, Iannetti P et al (1994) Hypoparathyroidism as the major manifestation in two patients with 22q11 deletions. Am J Med Genet 52:478–482PubMedCrossRefGoogle Scholar
  29. 29.
    Greig F, Paul E, DiMartino-Nardi J et al (1996) Transient congenital hypoparathyroidism: Resolution and recurrence in chromosome 22q11 deletion. J Pediatr 128:563–567PubMedCrossRefGoogle Scholar
  30. 30.
    Jawad AF, McDonald-McGinn DM, Zackai E et al (2001) Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Pediatr 139:715–723PubMedCrossRefGoogle Scholar
  31. 31.
    Sullivan KE (2004) The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome. Curr Opin Allergy Clin Immunol 4:505–512PubMedCrossRefGoogle Scholar
  32. 32.
    DiGeorge AM (1968) Congenital absence of the thymus and its immunological consequences: Concurrance with congenital hypothyroidism. Birth Defects 4:116–121Google Scholar
  33. 33.
    Barrett DJ, Ammann AJ, Wara DW et al (1981) Clinical and immunologic spectrum of the DiGeorge syndrome. J Clin Lab Immunol 6:1–6PubMedGoogle Scholar
  34. 34.
    Bastian J, Law S, Vogler L et al (1989) Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr 115:391–396PubMedCrossRefGoogle Scholar
  35. 35.
    Chinen J, Rosenblatt HM, Smith EO et al (2003) Longterm assessment of T-cell populations in DiGeorge syndrome. J Allergy Clin Immunol 111:573PubMedCrossRefGoogle Scholar
  36. 36.
    Sullivan KE, McDonald-McGinn D, Driscoll DA et al (1999) Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Diagn Lab Immunol 6:906PubMedGoogle Scholar
  37. 37.
    Gennery AR, Barge D, O’Sullivan JJ et al (2002) Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child 86:422PubMedCrossRefGoogle Scholar
  38. 38.
    Smith CA, Driscoll DA, Emanuel BS et al (1998) Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Diagn Lab Immunol 5:415PubMedGoogle Scholar
  39. 39.
    Davies K, Stiehm ER, Woo P, Murray KJ (2001) Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome. J Rheumatol 28:2326–2334PubMedGoogle Scholar
  40. 40.
    Davies JK, Telfer P, Cavenagh JD et al (2003) Autoimmune cytopenias in the 22q11.2 deletion syndrome. Clin Lab Haematol 25:195–197PubMedCrossRefGoogle Scholar
  41. 41.
    Lawrence S, McDonald-McGinn DM, Zackai E, Sullivan KE (2003) Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome. J Pediatr 143:277–278PubMedCrossRefGoogle Scholar
  42. 42.
    Kratz CP, Niehues T, Lyding S et al (2003) Evans syndrome in a patient with chromosome 22q11.2 deletion syndrome: A case report. Pediatr Hematol Oncol 20:167–172PubMedCrossRefGoogle Scholar
  43. 43.
    Digilio MC, Giannotti A, Castro M et al (2003) Screening for celiac disease in patients with deletion 22q11.2 (DiGeorge/velo-cardio-facial syndrome). Am J Med Genet 121A:286–288CrossRefPubMedGoogle Scholar
  44. 44.
    Scattone A, Caruso G, Marzullo A et al (2003) Neoplastic disease and deletion 22q11.2: A multicentric study and report of two cases. Pediatr Pathol Mol Med 22:323–341PubMedCrossRefGoogle Scholar
  45. 45.
    McDonald-McGinn DM, Reilly A, Wallgren-Pettersson C et al (2006) Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Am J Med Genet A 140:906PubMedGoogle Scholar
  46. 46.
    Simon TJ, Bearden CE, Moss EM et al (2002) Cognitive development in VCFS. Prog Pediatr Cardiol 15:109–117CrossRefGoogle Scholar
  47. 47.
    Fine SE, Weissman A, Gerdes M et al (2005) Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. J Autism Dev Disord 35:70CrossRefGoogle Scholar
  48. 48.
    Shprintzen RJ, Goldberg RB, Lewin ML et al (1978) A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: Velo-cardio-facial syndrome. Cleft Palate J 15:56PubMedGoogle Scholar
  49. 49.
    Dadmanesh F, Sekihara T, Rosai J (2001) Histologic typing of thymoma according to the new World Health Organization classification. Chest Surg Clin N Am 11:407–420PubMedGoogle Scholar
  50. 50.
    Ito M, Taki T, Miyake M et al (1988) Lymphocyte subsets in human thymoma studied with monoclonal antibodies. Cancer 61:284–287PubMedCrossRefGoogle Scholar
  51. 51.
    Chan WC, Zaatari GS, Tabei S et al (1984) Thymoma: An immunohistochemical study. Am J Clin Pathol 82:160–166PubMedGoogle Scholar
  52. 52.
    Bernatz PE, Harrison EG, Clagett OT (1961) Thymoma: A clinicopathologic study. Thorac Cardiovasc Surg 42:424–444Google Scholar
  53. 53.
    Gray GF, Gutowsk III WT (1979) Thymoma. A clinicopathologic study of 54 cases. Am J Surg Pathol 3:235–249PubMedGoogle Scholar
  54. 54.
    Pescarmona E, Rendina EA, Venuta F et al (1990) The prognostic implication of thymoma histologic subtyping. A study of 80 consecutive cases Am J Clin Pathol 93:190–195PubMedGoogle Scholar
  55. 55.
    Lattes R, Jonas S (1957) Pathological and clinical features in 80 cases of thymoma. Bull N Y Acad Med 33:145–147Google Scholar
  56. 56.
    Marino M, Muller-Hermelink HK (1985) Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol 407:119–149PubMedCrossRefGoogle Scholar
  57. 57.
    Kirchner T, Muller-Hermelink HK (1989) New approaches to the diagnosis of thymic epithelial tumors. Prog Surg Pathol 10:167–189Google Scholar
  58. 58.
    Quintanilla-Martinez L, Wilkins EW Jr, Choi N, Efird J et al (1994) Thymoma. Histologic subclassification is an independent prognostic factor. Cancer 74:606–617PubMedCrossRefGoogle Scholar
  59. 59.
    Rosai J, Sobin LH (1999) Histological typing of tumours of the thymus. WHO, International histologic classification of tumors. Springer-Verlag, BerlinGoogle Scholar
  60. 60.
    Chalabreysse L, Roy P, Cordier JF et al (2002) Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: A retrospective study of 90 tumors. Am J Surg Pathol 26:1605–1611PubMedCrossRefGoogle Scholar
  61. 61.
    Ströbel P, Marx A, Zettl A, (2005) Thymoma and thymic carcinoma: An update of the WHO Classification 2004. Surg Today 35:805–811PubMedCrossRefGoogle Scholar
  62. 62.
    Suster S, Moran CA (2006) Thymoma classification: Current status and future trends. Am J Clin Pathol 125:542–554PubMedGoogle Scholar
  63. 63.
    Kuo T (2000) Cytokeratin profiles of the thymus and thymomas: Histogenetic correlations and proposal for a histological classification of thymomas. Histopathology 36:403PubMedCrossRefGoogle Scholar
  64. 64.
    Masaoka A, Monden Y, Nakahara K et al (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485–2492PubMedCrossRefGoogle Scholar
  65. 65.
    Okumura MD, Ohta M, Tateyama H (2002) A clinical study of 273 patients. Cancer 94:624–632PubMedCrossRefGoogle Scholar
  66. 66.
    Sonobi S, Miyamoto H, Ozumi H (2005) Clinical usefulness of the WHO histological classification of thymoma. Ann of Thorac Cardiovasc Surg 11:367–373Google Scholar
  67. 67.
    Kondo K, Yoshizawa K et al (2004) WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 77:1183–1188PubMedCrossRefGoogle Scholar
  68. 68.
    Kim DJ, Yang WI, Choi SS et al (2005) Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: A clinicopathologic study of 108 patients and literature review. Chest 127:755–761PubMedCrossRefGoogle Scholar
  69. 69.
    Rena O, Papalia E, Maggi G et al (2005) World Health Organization histologic classification: An independent prognostic factor in resected thymomas. Lung Cancer 50:59–66PubMedCrossRefGoogle Scholar
  70. 70.
    Chen G, Marx A, Wen-Hu C (2002) New WHO histologic classification predicts prognosis of thymic epithelial tumors. A clinicopathologic study of 200 thymoma cases from China. Cancer 95:420–429PubMedCrossRefGoogle Scholar
  71. 71.
    Thomas CR, Wright CD, Loehrer PJ (1999) Thymoma: State of the art. J Clin Oncol 17:2280–2289PubMedGoogle Scholar
  72. 72.
    Patterson GA (1992) Thymomas. Semin Thorac Cardiovasc Surg 4:39–44PubMedGoogle Scholar
  73. 73.
    Engels EA, Pfeiffer RM (2003) Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 105:546–551PubMedCrossRefGoogle Scholar
  74. 74.
    Spigland N, Di Lorenzo M, Youssef S et al (1990) Malignant thymoma in children: A 20-year review. J Pediatr Surg 25:1143–1146PubMedCrossRefGoogle Scholar
  75. 75.
    Cohen DJ, Ronnigen LD, Graeber GM et al (1984) Management of patients with malignant thymoma. J Thorac Cardiovasc Surg 87:301PubMedGoogle Scholar
  76. 76.
    Sperling B, Marschall J, Kennedy R (2003) Thymoma: A review of the clinical and pathological findings in 65 cases Can J Surg 46:37–42PubMedGoogle Scholar
  77. 77.
    Morgenthaler TI, Brown LR, Colby TV et al (1993) Thymoma. Mayo Clin Proc 68:1110–1123PubMedGoogle Scholar
  78. 78.
    Moran CA, Travis WD, Rosado-de-Christenson M et al (1992) Thymomas presenting as pleural tumors. Report of eight cases. Am J Surg Pathol 16:138PubMedGoogle Scholar
  79. 79.
    Nishimura T, Kondo M, Miyazaki S et al (1982) Two-dimensional echocardiographic findings in cardiovascular involvement by invasive thymoma. Chest 81:752–754PubMedCrossRefGoogle Scholar
  80. 80.
    McAllister HA, Fenoglio JJ (1978) Atlas of tumor pathology. Tumors of the cardiovascular system. Second series, fascicle 15. Armed Forces Institute of Pathology, Washington DCGoogle Scholar
  81. 81.
    Blumberg D, Burt ME, Bains MS et al (1998) Thymic carcinoma: Current staging does not predict prognosis. J Thorac Cardiovasc Surg 115:303–9PubMedCrossRefGoogle Scholar
  82. 82.
    Abiko M, Sato T, Shiono S et al (1999) A case of invasive thymoma displaying endobronchial extension. J Jpn Soci Bronch 21:289–293Google Scholar
  83. 83.
    Sakuraba M, Sagara Y, Tamura A (2005) A case of invasive thymoma with endobronchial growth. Ann Thorac Cardiovasc Surg 11(2):114–116PubMedGoogle Scholar
  84. 84.
    Wright C, Wain C (2006) Acute presentation of thymoma with infarction or hemorrhage. Ann Thorac Surg 82:1901–1904PubMedCrossRefGoogle Scholar
  85. 85.
    Jung JI, Kim HH, Park SH (1999) Malignant ectopic thymoma in the neck: A case report. Am J Neuroradiol 20:1747–1749PubMedGoogle Scholar
  86. 86.
    Silverman NA, Sabiston DC Jr (1980) Mediastinal masses. Surg Clin North Am 60:757–777PubMedGoogle Scholar
  87. 87.
    Lennon VA, Lambert EH (1980) Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors. Nature 285:238–240PubMedCrossRefGoogle Scholar
  88. 88.
    Souadjian JV, Enriquez P, Silverstein MN et al (1974) The spectrum of diseases associated with thymoma. Coincidence or syndrome? Arch Intern Med 134:374–379PubMedCrossRefGoogle Scholar
  89. 89.
    Shields TW (1991) Thymic tumors. In: Shields TW (ed) Mediastinal surgery. Lea & Febiger, PhiladelphiaGoogle Scholar
  90. 90.
    Hayashi A, Shiono H, Okumura M (2007) Thymoma accompanied by lichen planus. Interact Cardiovasc Thorac SurgGoogle Scholar
  91. 91.
    Bailey RO, Dunn HG, Rubin AM et al (1988) Myasthenia gravis with thymoma and pure red blood cell aplasia. Am J Clin Pathol 89:687–693PubMedGoogle Scholar
  92. 92.
    Krantz SB (1990) Pure red cell aplasia. In: Givel JC, Merlini M, Clarke DB, Dusmet M (eds) Surgery of the thymus. Pathology, associated disorders and surgical technique. Springer-Verlag, BerlinGoogle Scholar
  93. 93.
    Palmieri G, Lastoria S, Colao A et al (1997) Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone. N Engl J Med 336:263PubMedCrossRefGoogle Scholar
  94. 94.
    Good RA (1954) Agammaglobulinemia: A provocative experiment of nature. Bull Univ Minn Hosp 26:1Google Scholar
  95. 95.
    Rosenberg JC (1993) Neoplasms of the mediastinum. In: DeVita Jr VT, Hellman S, Rosenberg SA (eds) Cancer. Principles and practice of oncology, 4th edn. JB Lippincott, PhiladelphiaGoogle Scholar
  96. 96.
    Rosado de Christenson ML, Galobardes J, Moran CA (1992) Thymoma: Radiologic-pathologic correlation. Radiographics 12:151–168PubMedGoogle Scholar
  97. 97.
    Kiyosue H, Miyake H, Komatsu E, Mori H (1994) MRI of cervical masses of thymic origin. J Comput Assist Tomogr 18:206–208PubMedCrossRefGoogle Scholar
  98. 98.
    Sakai F, Sone S, Kiyono K et al (1992) MR imaging of thymoma: Radiologic-pathologic correlation. AJR Am J Roentgenol 158:751–756PubMedGoogle Scholar
  99. 99.
    Lastoria S, Vergara E, Palmieri G et al (1998) In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phel-octreotide scintigraphy. J Nucl Med 39:634–639PubMedGoogle Scholar
  100. 100.
    Liu RS, Yeh SH, Huang MH et al (1995) Use of fluorine—18 fluorodeoxyglucose positron emission tomography in the detection of Thymoma: A preliminary report. Eur J Nucl Med 22:1402–1407PubMedCrossRefGoogle Scholar
  101. 101.
    Lewis JE, Wick MR, Scheithauer BW et al (1987) Thymoma: A clinicopathologic review. Cancer 60:2727–2743PubMedCrossRefGoogle Scholar
  102. 102.
    Blumberg D, Port JL, Weksler B et al (1995) Thymoma: A multivariate analysis of factors predicting survival. Ann Thorac Surg 60:908–913PubMedCrossRefGoogle Scholar
  103. 103.
    Kohman LJ (1997) Controversies in the management of malignant thymoma. Chest 112:296S–300SPubMedCrossRefGoogle Scholar
  104. 104.
    Gripp S, Hilgers K, Wurm R (1998) Thymoma: Prognostic factors and treatment outcomes. Cancer 83:1495–1503PubMedCrossRefGoogle Scholar
  105. 105.
    Kurup A, Loehrer PJ Sr (2004) Thymoma and thymic carcinoma: Therapeutic approaches. Clin Lung Cancer 6:28–32PubMedCrossRefGoogle Scholar
  106. 106.
    Curran WJ Jr, Kornstein MJ, Brooks JJ, Turrisi AT 3rd (1988) Invasive thymoma: The role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 6:1722–1727PubMedGoogle Scholar
  107. 107.
    Hsu CP, Chen CY, Chen CL et al (1994) Thymic carcinoma: Ten years’ experience in twenty patients. J Thorac Cardiovasc Surg 107:615–620PubMedGoogle Scholar
  108. 108.
    Walker AN, Mills SE, Fechner RE (1990) Thymomas and thymic carcinomas. Semin Diagn Pathol 7:250–265PubMedGoogle Scholar
  109. 109.
    Ritter JH, Wick MR (1999) Primary carcinomas of the thymus gland. Semin Diagn Pathol 16:18–31PubMedGoogle Scholar
  110. 110.
    Chung DA (2000) Thymic carcinoma — Analysis of nineteen clinicopathological studies. Thorac Cardiovasc Surg 48:114–119PubMedCrossRefGoogle Scholar
  111. 111.
    Hishima T, Fukayama M, Fujisawa M et al (1994) CD5 expression in thymic carcinoma. Am J Pathol 145:268–275PubMedGoogle Scholar
  112. 112.
    Suster S, Rosai J (1991) Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer 67:1025–1032PubMedCrossRefGoogle Scholar
  113. 113.
    Wick MR, Scheithauer BW, Weiland LH et al (1982) Primary thymic carcinomas. Am J Surg Pathol 6:613–630PubMedCrossRefGoogle Scholar
  114. 114.
    Leyvraz S, Henle W, Chahinian AP et al (1985) Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 312:1296–1299PubMedGoogle Scholar
  115. 115.
    Lee JD, Choe KO, Kim SJ et al (1991) CT findings in primary thymic carcinoma. J Comput Assist Tomogr 15:429–433PubMedCrossRefGoogle Scholar
  116. 116.
    Thomas CR, Wright CD, Loehrer PJ (1999) Thymoma: State of the art. J Clin Oncol 17:2280–2289PubMedGoogle Scholar
  117. 117.
    Wick MR, Rosai J (1990) Neuroendocrine, germ cell, and nonepithelial tumors. In: Givel JC, Merlini M, Clarke DB, Dusmet M (eds) Surgery of the thymus. Pathology, associated disorders and surgical technique. Springer-Verlag, BerlinGoogle Scholar
  118. 118.
    Burns DE, Schiffman FJ (1993) Beguiled by the gallium: Thymic rebound in an adult after chemotherapy for Hodgkin’s disease. Chest 104:1916–1919PubMedCrossRefGoogle Scholar
  119. 119.
    Rios A, Torres J, Roca MJ (2006) Primary thymic lymphomas. Rev Clin Esp 206:326–331PubMedCrossRefGoogle Scholar
  120. 120.
    Inagaki H, Chan JK, Ng JW et al (2002) Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features. Am J of Path 160:1435–1443Google Scholar
  121. 121.
    Shimizu K, Ishii G, Nagai K et al (2005) Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue (MALT Lymphoma) in the Thymus: Report of Four Cases. Japanese Journal of Clinical Oncology 35:412–416PubMedCrossRefGoogle Scholar
  122. 122.
    Tiffet O, Nicholson AG, Ladas G et al (2003) A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Chest 124:141–146PubMedCrossRefGoogle Scholar
  123. 123.
    Wick MR, Scott RE, Li CY et al (1980) Carcinoid tumor of the thymus: A clinicopathologic report of seven cases with a review of the literature. Mayo Clin Proc 55:246–254PubMedGoogle Scholar
  124. 124.
    Fukai I, Masaoka A, Fujii Y et al (1999) Thymic neuroendocrine tumor (thymic carcinoid): A clinicopathologic study in 15 patients. Ann Thorac Surg 67:208–211PubMedCrossRefGoogle Scholar
  125. 125.
    De Montpreville VT, Macchiarini P, Dulmet E (1996) Thymic neuroendocrine carcinoma (carcinoid): A clinicopathologic study of fourteen cases. J Thorac Cardiovasc Surg 111:134–141PubMedCrossRefGoogle Scholar
  126. 126.
    Economopoulos G, Lewis J Jr, Lee M et al (1990) Carcinoid tumors of the thymus. Ann Thorac Surg 50:58–61PubMedCrossRefGoogle Scholar
  127. 127.
    Yamakawa Y, Masaoka A, Hashimoto T et al (1991) A tentative tumor-node-metastasis classification of thymoma. Cancer 68:1984–1987PubMedCrossRefGoogle Scholar
  128. 128.
    Gelfand E, Basualdo C, Callaghan J (1981) Carcinoid tumor of the thymus associated with recurrent pericarditis. Chest 79:350–351PubMedCrossRefGoogle Scholar
  129. 129.
    Wick MR, Rosai J (1991) Neuroendocrine neoplasms of the mediastinum. Semin Diagn Pathol 8:35–51PubMedGoogle Scholar
  130. 130.
    Moran CA, Suster S, Fishback N, Koss MN (1993) Mediastinal paragangliomas: A clinicopathologic and immunohistochemical study of 16 cases. Cancer 72:2358–2364PubMedCrossRefGoogle Scholar
  131. 131.
    Pneumocystis pneumonia — Los Angeles, 1981 (1996) MMWR Morb Mortal Wkly Rep 30:250–252Google Scholar
  132. 132.
    Barre-Sinoussi F, Chermann JC, Rey F et al (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868–871PubMedCrossRefGoogle Scholar
  133. 133.
    Joshi VV (1991) Pathologic changes associated with HIV infection in children. In: Pizzo PA, Wilfred CM (eds) Pediatric AIDS. Williams & Wilkins, BaltimoreGoogle Scholar
  134. 134.
    Leonidas J, Berdon W, Valderrama E et al (1996) Human immunodeficiency virus infection and multilocular thymic cysts. Radiology 198:377–379PubMedGoogle Scholar
  135. 135.
    Avila N, Mueller B, Carrasquillo J et al (1996) Multilocular thymic cysts: Imaging features in children with human immunodeficiency virus infection. Radiology 201:130–134PubMedGoogle Scholar
  136. 136.
    Haynes BF, Hale LP, Weinhold KJ et al (1999) Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest 103:453–460PubMedCrossRefGoogle Scholar
  137. 137.
    Haynes BF, Hale LP (1998) The human thymus: A chimeric organ comprised of central and peripheral lymphoid components. Immunol Res 3:175–92CrossRefGoogle Scholar
  138. 138.
    Haynes BF, Hale LP, Weinhold KJ et al (1999) Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest 103:921PubMedCrossRefGoogle Scholar
  139. 139.
    Sopper S, Nierwetberg D, Halbach A et al (2003) Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers and T-cell turnover in different organs of rhesus monkeys. Blood 101:1213–1219PubMedCrossRefGoogle Scholar
  140. 140.
    Autran B, Carcelain G, Li TS et al (1997) Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277:112–116PubMedCrossRefGoogle Scholar
  141. 141.
    Zhang ZQ, Notermans DW, Sedgewick G et al (1998) Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci U S A 95:1154–1159PubMedCrossRefGoogle Scholar
  142. 142.
    Duprez A, Cordier R, Schmitz P (1962) Tuberculoma of the thymus. First case of surgical excision. J Urol Nephrol 44:115–120Google Scholar
  143. 143.
    Simmers TA, Jie C, Sie MC (1997) Thymic tuberculosis: A case report. Neth J Med 51:87–90PubMedCrossRefGoogle Scholar
  144. 144.
    FitzGerald JM, Mayo JR, Miller RR et al (1992) Tuberculosis of the thymus. Chest 102:1604–1605PubMedCrossRefGoogle Scholar
  145. 145.
    Nobrega C, Cardona PJ, Roque S et al (2007) The thymus as a target for mycobacterial infections. Microbes Infect 9:1521–1529PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2008

Authors and Affiliations

  • Ghulam Khaleeq
    • 1
  • Hakim A. Ali
    • 1
  • Ali I. Musani
    • 2
  1. 1.Department of Pulmonary Diseases and Critical Care MedicineAlbert Einstein Medical CenterPhiladelphiaUSA
  2. 2.Pulmonary Allergy and Critical Care Medicine Interventional Pulmonology ProgramHospital of the University of PennsylvaniaPhiladelphiaUSA

Personalised recommendations